🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

U.S., Australia reach deal on pharma protection in TPP-Japan media

Published 2015-10-04, 10:40 a/m
© Reuters.  U.S., Australia reach deal on pharma protection in TPP-Japan media

ATLANTA, Oct 4 (Reuters) - The United States and Australia
have reached a compromise on the length of monopoly protection
allowed for new biotech drugs in a development that could clear
the way for a sweeping Pacific Rim trade deal, Japanese media
reported on Sunday.
The amount of time allowed for pharmaceutical companies to
have exclusive rights to the clinical data for biological drugs
has been the last major sticking point in the Trans-Pacific
Partnership talks in Atlanta.
The compromise under discussion would grant a data
exclusivity period that would be eight years, in effect, Kyodo
reported. That would be in line with a U.S. proposal from last
week. Reuters could not immediately confirm the report.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.